Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
aldesleukin (Proleukin) (1 trial)
cyclophosphamide (cytoxan) (1 trial)
pd-1 knockout t cells (1 trial)
Carcinoma, Non-Small-Cell Lung (Phase 1)
Lung Neoplasms (Phase 1)
Trials (1 total)
Trial APIs (3 total)